Kisspeptin-10 and libido claims: what the research actually supports

A recent TikTok video from California Leggs, titled “Hablando de kisspeptin o kisspeptina parte 2,” discusses Kisspeptin-10 in the context of peptide use. The clip, framed as personal experience rather than medical advice, suggests that Kisspeptin-10 can enhance libido and support reproductive function. While the creator’s enthusiasm is understandable, the 15-second format necessarily omits critical context about what the research actually shows.

What the clip is claiming

The video implies that Kisspeptin-10 is a straightforward libido booster, with effects that users can expect soon after administration. It also hints at broader benefits for hormonal health, possibly including fertility. However, the clip does not mention dosing, timing, or the fact that Kisspeptin-10 is a research compound, not a proven supplement.

What the research neighborhood actually covers

Kisspeptin is a neuropeptide that plays a central role in the hypothalamic-pituitary-gonadal (HPG) axis. It stimulates the release of gonadotropin-releasing hormone (GnRH), which in turn triggers luteinizing hormone (LH) and follicle-stimulating hormone (FSH) from the pituitary. In clinical studies, Kisspeptin-10 has been investigated for its ability to restore reproductive function in conditions like hypogonadism and to improve outcomes in assisted reproduction. Some small human trials have shown that a single infusion of Kisspeptin-10 can increase LH levels and, in some cases, enhance sexual arousal in men and women. However, these studies use intravenous administration under controlled conditions, not subcutaneous injections at home.

Limits, missing context, and what a 15-second clip cannot show

The primary limitation of the TikTok clip is its brevity. It cannot convey that the evidence for Kisspeptin-10’s libido-enhancing effects is preliminary and often based on acute, single-dose studies. Long-term safety and efficacy data are lacking. Additionally, the clip does not address that Kisspeptin-10 is not approved for human use by regulatory agencies; it is sold for research purposes only. The creator’s personal experience, while valid as anecdote, is not a substitute for peer-reviewed evidence. A 15-second clip also cannot explain the potential for side effects, such as injection site reactions, nausea, or the risk of disrupting the HPG axis if used improperly.

How this maps to named research compounds

Kisspeptin-10 is a catalog compound at peptides-pro, listed under its exact name. It is distinct from other peptides that affect reproductive or libido pathways, such as PT-141 (Bremelanotide), which acts on melanocortin receptors, or GHRP-6 and Hexarelin, which influence growth hormone secretion. Kisspeptin-10’s mechanism is unique: it directly stimulates GnRH neurons. For researchers, this makes it a valuable tool for studying reproductive neuroendocrinology. However, the catalog’s intended use is research only, not self-administration.

Research-use caveat

All peptides in the peptides-pro catalog are intended for laboratory research and in vitro studies only. They are not for human or veterinary use. Kisspeptin-10, like all research peptides, should be handled with appropriate safety protocols and used only in controlled experimental settings. The claims made in social media clips do not constitute evidence of safety or efficacy for human consumption.

Open the full video fact-check page (transcript, takeaways, embedded clip).